Friday 27 Sep, 2024 04:48 AM
Site map | Locate Us | Login
   Linc rallies after inking JV agreement with SILKA    K.P. Energy inks power purchase agreement with GUVNL    Krsnaa Diagnostics join hands with Apulki Healthcare for cancer and cardiac care    NTPC arm inks JV agreement with MAHAPREIT    Mukta Arts spurts on inking lucrative deal with Zee Entertainment    NBCC (India) wins order worth 75 crore from IIIT Nagpur    PB Fintech Ltd leads losers in 'A' group    Lancer Containers Lines Ltd leads losers in 'B' group    Ceinsys secures Rs 29.20 cr contract from CIDCO for GIS implementation    Power Mech bags order worth Rs 227 crore from Gujaraj Mineral Development Corp    Volumes spurt at Capri Global Capital Ltd counter    Power shares fall    Capital Goods shares slide    Consumer Durables stocks slide    Hindalco Industries Ltd up for third consecutive session 
Saravan Stocks
       
Hot Pursuit
Scrips, which has significant changes during the market hours.
Torrent Pharma's Madhya Pradesh facility concludes GMP inspection with 1 observation
20-Sep-24   14:40 Hrs IST

The GMP inspection was conducted from 16 September to 20 September 2024. At the conclusion of the inspection, the USFDA has issued a Form FDA 483 with one observation which is procedural in nature.

The company said that it will respond to the USFDA within the prescribed timeframe and will work closely with the Agency to address the observation at the earliest possible time.

Torrent Pharmaceuticals is the flagship company of the Torrent Group. It is ranked 6th in the Indian Pharmaceuticals Market and is amongst the top five in the therapeutics segments of cardiovascular (CV), gastro intestinal (GI), central nervous system (CNS), vitamins minerals nutritional (VMN) and cosmo-dermatology.

The company's consolidated net profit increased 20.9% to Rs 457 crore in Q1 FY25 as compared with Rs 378 crore recorded in Q1 FY24. Revenue from operations rose 10.34% year on year (YoY) to Rs 2,859 crore in the quarter ended 30 June 2024.

The scrip advanced 2.97% to Rs 3,450 on the BSE.

Powered by Capital Market - Live News

   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com,  Mobile No: 7305522205
Hit Count : 35739497
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 56990 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. SSPL WEALTH Pvt. Ltd